ALZAMEND NEURO INC's ticker is ALZN and the CUSIP is 02262M308. A total of 25 filers reported holding ALZAMEND NEURO INC in Q1 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $5,104 | -33.8% | 12,009 | -12.0% | 0.00% | – |
Q4 2022 | $7,711 | -77.3% | 13,651 | -51.1% | 0.00% | – |
Q1 2022 | $34,000 | -87.4% | 27,928 | -80.3% | 0.00% | – |
Q4 2021 | $269,000 | +60.1% | 141,414 | +160.0% | 0.00% | – |
Q3 2021 | $168,000 | -85.6% | 54,396 | -59.3% | 0.00% | – |
Q2 2021 | $1,169,000 | – | 133,725 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RFG Advisory, LLC | 250,000 | $59,250 | 0.00% |
TRUIST FINANCIAL CORP | 2,314,907 | $548,633 | 0.00% |
XTX Topco Ltd | 12,974 | $3,075 | 0.00% |
UBS Group AG | 7,927 | $1,879 | 0.00% |
IFP Advisors, Inc | 5,000 | $1,185 | 0.00% |
OSAIC HOLDINGS, INC. | 1,000 | $237 | 0.00% |
FMR LLC | 268 | $64 | 0.00% |
WELLS FARGO & COMPANY/MN | 495 | $117 | 0.00% |
NORTHERN TRUST CORP | 103,775 | $24,595 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |